RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 85-96
  • Looking beyond Avandia for diabetes treatment

    Looking beyond Avandia for diabetes treatment
    The safety of most diabetes drugs are time-tested — insulin was discovered in the early 1920s, and two of the other most commonly prescribed, metformin and sulfonylurea, have been around since the 1950s. Avandia is different. The drug landed with a...
  • Jailed Psychiatrist Pleads Guilty

    Jailed Psychiatrist Pleads Guilty
    Sentenced On Charges Of Falsified Records Of Clinical Trials Involving Children. DR. MARIA CARMEN PALAZZO, age 58, pled guilty in federal court today before U. S. District Judge Mary Ann Vial Lemmon to fifteen (15) counts of failing to prepare and...
  • Glaxo adds safety restrictions to Avandia label

    Glaxo adds safety restrictions to Avandia label
    WASHINGTON (AP) -- GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack. The Food and Drug Administration...
  • Gates Foundation to improve child vaccines in China

    Gates Foundation to improve child vaccines in China
    The Bill and Melinda Gates Foundation is helping partners in China improve child vaccines, roll out faster TB detection kits and make higher-yielding rice which it hopes can be used later in other parts of the world. Ray Yip, the foundation's chief...
  • Doctors supplement income via drug companies

    A cardiologist, endocrinologist, psychiatrist, nurse practitioner and allergist. These five medical professionals in Burbank and Glendale may have different specialties, but they have one source of income in common — drug companies. Since 2009, 33...
  • Genital warts tied to range of cancers

    Genital warts tied to range of cancers
    NEW YORK (Reuters Health) - People who've ever had genital warts may have a somewhat higher risk of several types of cancer — possibly including common skin cancers, a new study suggests. The findings, reported in the Journal of Infectious...
  • Asthma drugs may increase attacks in kids: report

    Asthma drugs may increase attacks in kids: report
    NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
  • Study: At-home cervical cancer test could save thousands

    A do-it-yourself test for cervical cancer could help prevent thousands of cases of the disease in women who don't have easy or regular access to smear tests, scientists said Wednesday. The DIY test, which detects the human papillomavirus (HPV)...
  • IUDs almost halve risk of cervical cancer: study

    IUDs almost halve risk of cervical cancer: study
    LONDON (Reuters) - Contrary to popular belief, intrauterine contraceptive devices might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease, according to the results of...
  • Tailored breast cancer drugs in focus at cancer meet

    Tailored breast cancer drugs in focus at cancer meet
    ZURICH (Reuters) - Doctors and investors at a cancer conference starting on Friday will be keen to find out more on the effectiveness of two promising new breast cancer drugs from Swiss drugmakers Roche and Novartis. Roche's T-DM1 and Novartis's Afinitor...
  • UK switches to Merck's Gardasil for HPV vaccination

    UK switches to Merck's Gardasil for HPV vaccination
    LONDON (Reuters) - Britain is to stop using GlaxoSmithKline's cervical cancer vaccine Cervarix from next September and will instead offer girls Merck & Co's rival product Gardasil. The move underscores Gardasil's lead in a $1 billion-plus worldwide...
  • Cancer study boosts hopes for Roche's armed antibody

    Cancer study boosts hopes for Roche's armed antibody
    STOCKHOLM (Reuters) - Women with an aggressive type of advanced breast cancer can live significantly longer without their disease getting worse if they are treated with an experimental "armed antibody" drug from Roche, researchers said on Sunday. Data...